Retatrutide — Triple Agonist Research Peptide
Retatrutide is a novel triple agonist peptide targeting GIP, GLP-1, and glucagon receptors simultaneously. This groundbreaking compound represents the next generation of metabolic research peptides, offering researchers a powerful tool for studying multi-receptor activation pathways.
Research Applications
- Multi-receptor metabolic pathway studies
- Weight management research protocols
- Glucose homeostasis investigation
- Appetite regulation mechanism studies
Specifications
- Purity: ≥99% (HPLC verified)
- Form: Lyophilized powder
- Storage: -20°C recommended
- For research use only
Reviews
There are no reviews yet.